These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38928147)

  • 61. Autosomal dominant neovascular inflammatory vitreoretinopathy with CAPN5 c.731T > C gene mutation; clinical management of a family cohort and review of the literature.
    Tabbaa T; Mehra AA; Kesav NP; Mahajan VB; Swanson RD; Zubricky R; Sobol WM
    Ophthalmic Genet; 2023 Dec; 44(6):559-567. PubMed ID: 37782277
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ophthalmic features of minimal pigment oculocutaneous albinism.
    Summers CG; King RA
    Ophthalmology; 1994 May; 101(5):906-14. PubMed ID: 8190479
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse.
    Giebel LB; Tripathi RK; King RA; Spritz RA
    J Clin Invest; 1991 Mar; 87(3):1119-22. PubMed ID: 1900309
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Germline variants in oculocutaneous albinism genes and predisposition to familial cutaneous melanoma.
    Nathan V; Johansson PA; Palmer JM; Howlie M; Hamilton HR; Wadt K; Jönsson G; Brooks KM; Pritchard AL; Hayward NK
    Pigment Cell Melanoma Res; 2019 Nov; 32(6):854-863. PubMed ID: 31233279
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of Five Novel Variants in Chinese Oculocutaneous Albinism by Targeted Next-Generation Sequencing.
    Qiu B; Ma T; Peng C; Zheng X; Yang J
    Genet Test Mol Biomarkers; 2018 Apr; 22(4):252-258. PubMed ID: 29437493
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification and characterization of two novel noncoding tyrosinase (TYR) gene variants leading to oculocutaneous albinism type 1.
    Li C; Chen Q; Wu J; Ren J; Zhang M; Wang H; Li J; Tang Y
    J Biol Chem; 2022 May; 298(5):101922. PubMed ID: 35413289
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies.
    Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC
    Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular genetic studies and delineation of the oculocutaneous albinism phenotype in the Pakistani population.
    Jaworek TJ; Kausar T; Bell SM; Tariq N; Maqsood MI; Sohail A; Ali M; Iqbal F; Rasool S; Riazuddin S; Shaikh RS; Ahmed ZM
    Orphanet J Rare Dis; 2012 Jun; 7():44. PubMed ID: 22734612
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A comprehensive genetic study of autosomal recessive ocular albinism in Caucasian patients.
    Hutton SM; Spritz RA
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):868-72. PubMed ID: 18326704
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tyrosinase gene mutations in the Chinese Han population with OCA1.
    Liu N; Kong XD; Shi HR; Wu QH; Jiang M
    Genet Res (Camb); 2014 Nov; 96():e14. PubMed ID: 25577957
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Oculocutaneous albinism in French overseas territories (Reunion, French Guyana, Martinique) and Mayotte. Study of 21 cases in 16 families].
    Aquaron R; Berge-Lefranc JL; Badens C; Roche J; Fite A; Sainte-Marie D; Piquion N; Cartault F
    Med Trop (Mars); 2005 Nov; 65(6):584-91. PubMed ID: 16555521
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Genetic analyses of Vietnamese patients with oculocutaneous albinism.
    Thuong MTH; Anh LTL; Nhung VP; Ngoc TTB; Lan HT; Phuong DK; Ha NH; Van Hai N; Ton ND
    J Clin Lab Anal; 2022 Sep; 36(9):e24625. PubMed ID: 35870188
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A novel de novo
    Velez G; Bassuk AG; Schaefer KA; Brooks B; Gakhar L; Mahajan M; Kahn P; Tsang SH; Ferguson PJ; Mahajan VB
    Cold Spring Harb Mol Case Stud; 2018 Jun; 4(3):. PubMed ID: 29472286
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Abnormal foveal morphology in carriers of oculocutaneous albinism.
    Kuht HJ; Thomas MG; McLean RJ; Sheth V; Proudlock FA; Gottlob I
    Br J Ophthalmol; 2023 Aug; 107(8):1202-1208. PubMed ID: 35379600
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular and clinical characterization of albinism in a large cohort of Italian patients.
    Gargiulo A; Testa F; Rossi S; Di Iorio V; Fecarotta S; de Berardinis T; Iovine A; Magli A; Signorini S; Fazzi E; Galantuomo MS; Fossarello M; Montefusco S; Ciccodicola A; Neri A; Macaluso C; Simonelli F; Surace EM
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1281-9. PubMed ID: 20861488
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Generation of a human induced pluripotent stem cell line carrying the TYR c.575C>A (p.Ser192Tyr) and c.1205G>A (p.Arg402Gln) variants in homozygous state using CRISPR-Cas9 genome editing.
    Liu J; Black GC; Kimber SJ; Sergouniotis PI
    Stem Cell Res; 2022 Oct; 64():102880. PubMed ID: 35933957
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Oculocutaneous and ocular albinism].
    Kubasch AS; Meurer M
    Hautarzt; 2017 Nov; 68(11):867-875. PubMed ID: 29018889
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prospective Study of the Phenotypic and Mutational Spectrum of Ocular Albinism and Oculocutaneous Albinism.
    Chan HW; Schiff ER; Tailor VK; Malka S; Neveu MM; Theodorou M; Moosajee M
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33808351
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Type I oculocutaneous albinism associated with a full-length deletion of the tyrosinase gene.
    Schnur RE; Sellinger BT; Holmes SA; Wick PA; Tatsumura YO; Spritz RA
    J Invest Dermatol; 1996 May; 106(5):1137-40. PubMed ID: 8618053
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mutation analysis of the tyrosinase gene in oculocutaneous albinism.
    Camand O; Marchant D; Boutboul S; Péquignot M; Odent S; Dollfus H; Sutherland J; Levin A; Menasche M; Marsac C; Dufier JL; Heon E; Abitbol M
    Hum Mutat; 2001 Apr; 17(4):352. PubMed ID: 11295837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.